SCHEMBL7779473

SCHEMBL7779473

CN(C)CCn1nc(-c2ccncc2)c(-c2ccc(S(N)(=O)=O)cc2)c1C(F)(F)F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.61
PTGS1 P23219 7/20 0.61
LRRK2 Q5S007 2/20 0.40
KIF11 P52732 1/20 0.38
CYP2C9 P11712 2/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
ALOX5 P09917 2/20 0.37
PTGES O14684 1/20 0.37
HDAC3 O15379 1/20 0.37
PDPK1 O15530 1/20 0.37
PDE5A O76074 1/20 0.37
ABCB11 O95342 1/20 0.37
MT-CO2 P00403 1/20 0.37
LMNA P02545 1/20 0.37
CA3 P07451 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADORA3 P0DMS8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7778122 1.00 PTGS2 (0.61) PTGS2PTGS1LRRK2KIF11CYP2C9
SCHEMBL7777915 0.91 PTGS2 (0.75) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779570 0.91 PTGS2 (0.62) PTGS2PTGS1CA12CA1CA2
SCHEMBL7778108 0.91 PTGS2 (0.61) PTGS2PTGS1ALOX5MAPK14
SCHEMBL7777885 0.91 PTGS2 (0.62) PTGS2PTGS1CYP2C9CA12CA1
SCHEMBL7777325 0.91 PTGS2 (0.61) PTGS2PTGS1ALOX5MAPK14
SCHEMBL7780881 0.90 PTGS2 (0.61) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779368 0.88 PTGS2 (0.59) PTGS2PTGS1CYP2C9CA12CA1
SCHEMBL7780599 0.88 PTGS2 (0.59) PTGS2PTGS1CA12CA1CA2
SCHEMBL7777556 0.86 PTGS2 (0.81) PTGS2PTGS1LRRK2KIF11CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed